MedPath

Bioequivalence study of Tofaxha 5mg

Not Applicable
Conditions
In this study, the disease is not examined. The subject of the study is the bioequivalence study of Tofacitinib 5mg tablet of test and reference in healthy volunteers..
Registration Number
IRCT20200623047902N2
Lead Sponsor
Zistdaru Danesh Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
24
Inclusion Criteria

General Health (Liver, Heart and Kidney)
Body Mass Index (18-28)
Conscious Consciousness
Age (18-60)

Exclusion Criteria

Smoking
History of cardiovascular disease
History of liver and kidney disease
Pregnancy
Alcoholism and Narcoticism
History of allergy to Tofacitinib

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath